Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2322624 | 0.88 | POLB (0.48) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL18702782 | 0.88 | POLB (0.67) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL6456633 | 0.84 | CA1 (0.46) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL3652875 | 0.84 | CA1 (0.46) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL6906660 | 0.84 | ALOX15 (0.58) | POLBMAPTGAAHIF1AALDH1A1 | |
| SCHEMBL31688147 | 0.81 | GAA (0.43) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL29006024 | 0.80 | POLB (0.41) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL1530696 | 0.78 | ALDH1A1 (0.58) | POLBMAPTHIF1ACYP1A2CYP2D6 | |
| SCHEMBL6456636 | 0.78 | POLB (0.39) | POLBMAPTGAAHIF1ACYP1A2 | |
| SCHEMBL22225306 | 0.78 | APEX1 (0.45) | POLBMAPTGAAHIF1ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114380828-B | Synthesis method and application of perylene diimide bicyclic compound | 北京理工大学 | 2023-04-28 | — | — | CN | claimed |
| CN-114380828-A | Synthetic method and application of perylene diimide-based bicyclic compound | 北京理工大学 | 2022-04-22 | — | — | CN | claimed |
| EP-4714959-A1 | LIGHT EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2026-03-25 | — | — | EP | disclosed |
| US-20250344600-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-11-06 | — | — | US | disclosed |
| US-20250204252-A1 | LIGHT EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-06-19 | — | — | US | disclosed |
| CN-120157692-A | Light emitting element, condensed polycyclic compound for light emitting element, and display device including light emitting element | 三星显示有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-119789754-A | Light-emitting device, electronic apparatus, electronic device, and organometallic compound | 三星显示有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119708065-A | Organic electroluminescent material and device thereof | 北京夏禾科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119638750-A | Compound, light-emitting device including the compound, electronic apparatus including the light-emitting device, and electronic device including the electronic apparatus | 三星显示有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-12209100-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-01-28 | — | — | US | disclosed |
| CN-119176841-A | Organic electroluminescent material and device thereof | 北京夏禾科技有限公司 | 2024-12-24 | — | — | CN | disclosed |
| EP-2178837-A2 | ISOPHTHALAMIDE DERIVATIVES INHIBITING BETA-SECRETASE ACTIVITY | COMENTIS, INC. (US) | 2010-04-28 | — | — | EP | disclosed |
| WO-2010010017-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-01-28 | — | — | WO | disclosed |
| US-20100021423-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2010-01-28 | — | — | US | disclosed |
| WO-2009042694-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009015369-A2 | COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF | COMENTIS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20030109051-A1 | Spin trap for use in biological systems | RANDOX LABORATORIES LTD (IE) | 2003-06-12 | — | — | US | disclosed |
| EP-1302771-A2 | Spin trap for use in biological systems | Randox Laboratories Ltd. (GB) | 2003-04-16 | — | — | EP | disclosed |
| US-4479899-A | OF POLYESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1984-10-30 | — | — | US | disclosed |
| US-4452609-A | Dyeing red with 2,6-dicyano-2'-sulfonamido-4'-amino-azo-benzenes | BAYER AKTIENGESELLSCHAFT (DE) | 1984-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250204252-A1 | LIGHT EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME | NR2E3, ESR1, ALDH1A2 | POLB 3791/4885MAPT 2556/4885GAA 2752/4885 |
| US-12209100-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | CYP1A1, OXER1, CYP2E1 | POLB 2785/4885MAPT 2183/4885GAA 2219/4885 |
| US-20100021423-A1 | Heterocyclic antiviral compounds | POLR2A, RRM2B, RRP1B | POLB 46/4885MAPT 4356/4885GAA 1969/4885 |
| US-20250344600-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, EML4, LEF1 | POLB 3163/4885MAPT 1790/4885GAA 3370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.